EV Biologics Revenue

In the year 2017, EV Biologics had annual revenue of $9.47M, down -0.34%. EV Biologics had revenue of $2.46M in the quarter ending June 30, 2017, a decrease of -78.05%.

Revenue

9.47M

Revenue Growth

-70.48%

P/S Ratio

0.09

Revenue / Employee

n/a

Employees

n/a

Market Cap

880.41K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2017	9.47M	-32.45K	-0.34%
Jun 30, 2017	9.51M	-33.14M	-77.71%
Jun 30, 2016	42.64M	-3.59M	-7.76%
Jun 30, 2015	46.23M	1.77M	3.99%
Jun 30, 2014	44.46M	1.98M	4.65%
Jun 30, 2013	Pro	Pro	Pro
Jun 30, 2012	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SS Innovations International	20.65M
Endo Inc.	1.76B
Veradigm	588.02M
Northwest Biotherapeutics	1.38M
Elite Pharmaceuticals	70.00M
Glass House Brands	200.90M
BioStem Technologies	301.83M
American Oncology Network	1.76B

Revenue Rankings

EV Biologics News

1 year ago - EV Biologics Updates on Funding and Sales - Accesswire
1 year ago - EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic - Accesswire
1 year ago - EV Biologics Appoints Senior Investment Banker as Corporate Finance Director - Accesswire
1 year ago - EV Biologics Hires Senior Chief Financial Officer - Accesswire
2 years ago - EV Biologics Signs Exclusive Distribution Agreement for South America - Accesswire
2 years ago - EV Biologics Generates Mesenchymal Stem Cell Lines - Accesswire
2 years ago - EV Biologics Updates on Excyte Subsidiary Funding - Accesswire
2 years ago - EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX - Accesswire

More News